摘要
慢性阻塞性肺疾病(COPD)是全球第四大死亡原因,引发重大社会经济负担。流感疫苗能显著降低COPD患者流感感染风险、减少急性加重次数、降低住院率,与其他疫苗联合接种可协同增效。疫苗安全性良好,经济效益显著,可减少医疗费用。目前,流感疫苗接种主要面临患者认知不足、医疗系统支持不够、社会文化经济因素等挑战。本文对COPD患者接种流感疫苗效果进行综述,为COPD患者的预防和管理提供科学依据。
Chronic obstructive pulmonary disease(COPD)is the fourth leading cause of death worldwide,causing a significant socioeconomic burden.This article reviews the effects of influenza vaccination on COPD and finds that influenza vaccine can significantly reduce the risk of influenza infection,reduce the number of acute exacerbations,and reduce the hospitalization rate in patients with COPD.The vaccine has a favorable safety profile and significant economic benefits,which can reduce medical costs.Currently,influenza vaccination mainly faces challenges such as insufficient patient awareness,insufficient support from the medical system,and socio-cultural and economic factors.Efforts should be focused on reducing the acute exacerbation of COPD patients and providing a scientific basis for the prevention and management of COPD patients.
作者
戚商阳芷
丰骏杰
巫舒君
赵明
方挺
王珊珊
Qi Shangyangzhi;Feng Junjie;Wu Shujun;Zhao Ming;Fang Ting;Wang Shanshan(School of Public Health,Health Science Center,Ningbo University,Ningbo 315211,China;The First Affiliated Hospital of Ningbo University,Ningbo 315211,Chin)
出处
《中华流行病学杂志》
北大核心
2025年第8期1489-1494,共6页
Chinese Journal of Epidemiology
基金
2024年宁波市哲学社会科学重点实验室(试点)课题(SY2024-002)
2024年宁波市公益性研究计划(2024S031)。
关键词
慢性阻塞性肺疾病
流感疫苗
研究进展
Chronic obstructive pulmonary disease
Influenza vaccine
Research progress
作者简介
通信作者:方挺,Email:fangting@nbu.edu.cn;通信作者:王珊珊,Email:fywangshanshan@nbu.edu.cn。
